NCT00798343View on ClinicalTrials.gov

Heterosubtypic Immune Responses to Influenza in Older People

PHASE1CompletedINTERVENTIONAL
Enrollment

292

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

September 30, 2013

Conditions
Influenza
Interventions
BIOLOGICAL

Seasonal vaccine

Non-adjuvanted seasonal influenza vaccine (total dose 45ug)

BIOLOGICAL

H5 vaccine

MF59-adjuvanted A/Vietnam/1194 H5N1 vaccine 7.5ug dose

Trial Locations (1)

LE1 5WW

University Hospitals Leicester, Leicester

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

collaborator

Public Health England

OTHER_GOV

collaborator

Novartis

INDUSTRY

lead

University Hospitals, Leicester

OTHER

NCT00798343 - Heterosubtypic Immune Responses to Influenza in Older People | Biotech Hunter | Biotech Hunter